MIND was a prospective, open-label trial that enrolled adults up to 80 years old with moderate-large (20-80 mL) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback